| Current Price | $10.48 | Mkt Cap | $164.9M |
|---|---|---|---|
| Open | $9.46 | P/E Ratio | -1.12 |
| Prev. Close | $9.74 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.46 - $10.68 | Volume | 138,434 |
| 52-Wk Range | $3.11 - $33.50 | Avg. Daily Vol. | 166,912 |
| Current Price | $10.48 | Mkt Cap | $164.9M |
|---|---|---|---|
| Open | $9.46 | P/E Ratio | -1.12 |
| Prev. Close | $9.74 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.46 - $10.68 | Volume | 138,434 |
| 52-Wk Range | $3.11 - $33.50 | Avg. Daily Vol. | 166,912 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about HARP.
Recs
romeos115
(28.53)
Submitted: 8/22/2020 9:37:51 PM :
Start Price:
$130.10
NASDAQ:HARP Score:
-122.46
Cutting edge research on cancer immunotherapies
Find the members with the highest scoring picks in HARP.
TheFall2021 (93.77) Score: +113.53
The Score Leader is the player with the highest score across all their picks in HARP.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TheFall2021 | 93.77 | 1/21/2021 |
|
5Y | $225.10 | -95.38% | +18.15% | +113.53 | 0 Comment | |
| eagles777 | 64.54 | 11/24/2023 |
|
3Y | $12.83 | -19.02% | -0.10% | -18.92 | 0 Comment | |
| Atn1027 | 29.62 | 10/24/2023 |
|
5Y | $7.07 | +46.96% | +7.57% | -39.39 | 0 Comment | |
| icewater3 | 72.42 | 1/28/2022 |
|
3M | $47.70 | -78.22% | +5.06% | -83.28 | 0 Comment | |
| dj8519 | < 20 | 1/14/2021 |
|
5Y | $206.30 | -94.96% | +19.44% | -114.40 | 0 Comment | |
| romeos115 | 28.53 | 8/27/2020 |
|
5Y | $130.10 | -92.01% | +30.45% | -122.46 | 1 Comment | |
| bonjourmesamis | < 20 | 10/28/2020 |
|
5Y | $150.80 | -93.11% | +36.90% | -130.01 | 0 Comment | |
| Toprope101 | 98.70 | 5/5/2020 |
|
5Y | $135.55 | -92.33% | +57.40% | -149.74 | 0 Comment | |
| TheSlightEdge | 99.09 | 8/14/2019 |
|
5Y | $122.90 | -91.55% | +59.71% | -151.25 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
